EV/EBITDA
0.07
0.000.00%
Wed, 12 Mar 2025 23:59:57 GMT
Summary
- As of March 13, 2025, RNAZ EV/EBITDA is 0.07, unchanged from the previous trading day.
- Over the past year, RNAZ EV/EBITDA has dropped by -0.17 (-70.83%).
- RNAZ EV/EBITDA is now -76.67% below its all-time high of 0.30.
Performance
RNAZ EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RNAZ EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | -8.1% | -9.8% |
| 1 m1 month | +117.5% | -118.0% | -90.5% |
| 3 m3 months | +130.4% | -130.9% | -86.0% |
| 6 m6 months | +138.9% | -138.6% | -87.9% |
| ytdytd | +275.0% | -263.8% | -70.0% |
| 1 y1 year | -70.8% | +74.1% | -94.9% |
| 5 y5 years | - | - | - |
RNAZ EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.40 | +117.5% | |
| 3 m | 3-month | 0.07 | at high | -0.43 | +116.3% |
| 6 m | 6-month | 0.07 | at high | -0.77 | +109.1% |
| 1 y | 1-year | 0.24 | -70.8% | -0.77 | +109.1% |
| 3 y | 3-year | 0.30 | -76.7% | -4.04 | +101.7% |
| 5 y | 5-year | 0.30 | -76.7% | -25.23 | +100.3% |
| alltime | all time | 0.30 | -76.7% | -25.23 | +100.3% |
TransCode Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.07(-275.0%) |
| 2024 | -0.04(-60.0%) |
| Date | Value |
|---|---|
| 2023 | -0.10(-54.5%) |
| 2022 | -0.22(-88.4%) |
| 2021 | -1.89 |
FAQ
- What is TransCode Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for TransCode Therapeutics?
- What is RNAZ EV/EBITDA year-to-date change?
- What is TransCode Therapeutics EV/EBITDA year-on-year change?
What is TransCode Therapeutics EV/EBITDA?
The current EV/EBITDA of RNAZ is 0.07
What is the all time high EV/EBITDA for TransCode Therapeutics?
TransCode Therapeutics all-time high EV/EBITDA is 0.30
What is RNAZ EV/EBITDA year-to-date change?
TransCode Therapeutics EV/EBITDA has changed by +0.11 (+275.00%) since the beginning of the year
What is TransCode Therapeutics EV/EBITDA year-on-year change?
Over the past year, RNAZ EV/EBITDA has changed by -0.17 (-70.83%)